https://www.selleckchem.com/pr....oducts/anlotinib-al3
No KT patient administered the standard dose had out-of-range levels. Peak GM level was significantly lower in KT patients administered an inappropriately reduced dose (p=0.05). Two patients had below-range peak levels. Apixaban treatment initiation had minimal influence on the level of immunosuppression. Further, it had no adverse impact on graft function. Similar to non-transplant patients, KT patients administered the standard 5-mg bid dosage had apixaban levels that were well within the recommended manufacturers' expected r
Like
Comment
Share
